2017
DOI: 10.1002/cpns.33
|View full text |Cite
|
Sign up to set email alerts
|

Animal Model of Chronic Migraine‐Associated Pain

Abstract: Migraine is a debilitating condition that affects hundreds of millions of people worldwide. A subset of these patients experience chronic migraine, resulting in long-term disability and a severely lowered quality of life. The development of novel migraine therapies has been slow, partially due to the small number of predictive animal models. We have recently developed a novel model of chronic migraine-associated pain, using the known human migraine trigger, nitroglycerin. Injection of nitroglycerin evokes an a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
42
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(43 citation statements)
references
References 30 publications
1
42
0
Order By: Relevance
“…Several studies indicate that NTG administration in rodents is a predictive model of migraine in humans [ 24 , 34 , 35 ]. In this study we aimed at developing and testing a chronic migraine-like model in rats, based on chronic and intermittent administration of NTG.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies indicate that NTG administration in rodents is a predictive model of migraine in humans [ 24 , 34 , 35 ]. In this study we aimed at developing and testing a chronic migraine-like model in rats, based on chronic and intermittent administration of NTG.…”
Section: Discussionmentioning
confidence: 99%
“…In humans with migraine but not control subjects, NTG causes a delayed migraine (without aura) indistinguishable from spontaneous attacks ( Iversen, 1995 ; Tassorelli et al, 1999 ). NTG testing is thus used as a preclinical model for migraine without aura ( Bates et al, 2010 ; Greco et al, 2014 ; Pradhan et al, 2014 ; Kaufmann et al, 2016 ; Moye and Pradhan, 2017 ). CSD is the physiological substrate of the migraine aura in humans, and thus is used in preclinical models of migraine with aura ( Ayata et al, 2006 ; Chen et al, 2006 ; Brennan et al, 2007 ; Theriot et al, 2012 ).…”
Section: Discussionmentioning
confidence: 99%
“…In our study, we developed a mouse CM model with repeated NTG injections that was first described by Pradhan et al [9]. In his research, chronic intermittent treatment with NTG not only produced acute mechanical hypersensitivity of the hind paw after each injection but also induced long-lasting basal hyperalgesia, which was alleviated by the migraine-preventive treatment of topiramate.…”
Section: Animal Model Of Chronic Migrainementioning
confidence: 94%
“…The vehicle control was 0.9% saline. There was no significant difference in mechanical thresholds between the 0.9% saline solution and the solution in which NTG was dissolved (6% propylene glycol, 6% alcohol, 0.9% saline) [9]. The animals received intraperitoneal (i.p.)…”
Section: Animal Modelling and Experimental Designmentioning
confidence: 99%